APA (7th ed.) Citation

T, T., EJ, G., KR, v. S., A, M., B, K., A, A., . . . CC, Z. (2026). Bimekizumab efficacy using IHS4 outcomes in hidradenitis suppurativa: Results from BE HEARD I and II. Journal of the European Academy of Dermatology and Venereology : JEADV. https://doi.org/10.1111/jdv.70356

Chicago Style (17th ed.) Citation

T, Tzellos, et al. "Bimekizumab Efficacy Using IHS4 Outcomes in Hidradenitis Suppurativa: Results from BE HEARD I and II." Journal of the European Academy of Dermatology and Venereology : JEADV 2026. https://doi.org/10.1111/jdv.70356.

MLA (9th ed.) Citation

T, Tzellos, et al. "Bimekizumab Efficacy Using IHS4 Outcomes in Hidradenitis Suppurativa: Results from BE HEARD I and II." Journal of the European Academy of Dermatology and Venereology : JEADV, 2026, https://doi.org/10.1111/jdv.70356.